Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis
- PMID: 31296507
- PMCID: PMC6624043
- DOI: 10.1136/bmjopen-2018-025880
Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis
Abstract
Objectives: To examine the effect of cannabis policy liberalisation (decriminalisation and legalisation) levels of use in adolescents and young adults.
Design: Systematic review and meta-analysis.
Inclusion criteria: Included studies were conducted among individuals younger than 25 years and quantitatively assessing consequences of cannabis policy change. We excluded articles: (A) exclusively based on participants older than 25 years; (B) only reporting changes in perceptions of cannabis use; (C) not including at least two measures of cannabis use; (D) not including quantitative data; and (E) reviews, letters, opinions and policy papers. PubMed, PsycINFO, Embase and Web of Science were searched through 1 March 2018.
Data extraction and synthesis: Two independent readers reviewed the eligibility of titles and abstracts and read eligible articles, and four authors assessed the risk of bias (Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies). Extracted data were meta-analysed. The protocol was registered with PROSPERO.
Results: 3438 records were identified via search terms and four via citation lists; 2312 were retained after removal of duplicates, 99 were assessed for eligibility and 41 were included in our systematic review. 13 articles examined cannabis decriminalisation, 20 examined legalisation for medical purposes and 8 examined legalisation for recreational purposes. Findings regarding the consequences of cannabis decriminalisation or legalisation for medical purposes were too heterogeneous to be meta-analysed. Our systematic review and meta-analysis suggest a small increase in cannabis use among adolescents and young adults following legalisation of cannabis for recreational purposes (standardised mean difference of 0.03, 95% CI -0.01 to -0.07). Nevertheless, studies characterised by a very low/low risk of bias showed no evidence of changes in cannabis use following policy modifications.
Conclusions: Cannabis policy liberalisation does not appear to result in significant changes in youths' use, with the possible exception of legalisation for recreational purposes that requires monitoring.
Trial registration number: CRD42018083950.
Keywords: adolescents; cannabis; marijuana; policy.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.Drug Alcohol Rev. 2020 Jul;39(5):555-567. doi: 10.1111/dar.13087. Epub 2020 May 20. Drug Alcohol Rev. 2020. PMID: 32436274 Free PMC article. Review.
-
Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA.Neuropharmacology. 2021 Aug 1;193:108610. doi: 10.1016/j.neuropharm.2021.108610. Epub 2021 May 16. Neuropharmacology. 2021. PMID: 34010617 Review.
-
Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review.BMJ Open. 2020 Sep 21;10(9):e035148. doi: 10.1136/bmjopen-2019-035148. BMJ Open. 2020. PMID: 32958480 Free PMC article.
-
Does cannabis legalisation change healthcare utilisation? A population-based study using the healthcare cost and utilisation project in Colorado, USA.BMJ Open. 2019 May 15;9(5):e027432. doi: 10.1136/bmjopen-2018-027432. BMJ Open. 2019. PMID: 31092662 Free PMC article.
-
Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis.JAMA Psychiatry. 2018 Jun 1;75(6):585-595. doi: 10.1001/jamapsychiatry.2018.0335. JAMA Psychiatry. 2018. PMID: 29710074 Free PMC article.
Cited by
-
Changes in cannabis policy and prevalence of recreational cannabis use among adolescents and young adults in Europe-An interrupted time-series analysis.PLoS One. 2022 Jan 12;17(1):e0261885. doi: 10.1371/journal.pone.0261885. eCollection 2022. PLoS One. 2022. PMID: 35020763 Free PMC article.
-
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.Drug Alcohol Rev. 2020 Jul;39(5):555-567. doi: 10.1111/dar.13087. Epub 2020 May 20. Drug Alcohol Rev. 2020. PMID: 32436274 Free PMC article. Review.
-
International differences in patterns of cannabis use among adult cigarette smokers: Findings from the 2018 ITC Four Country Smoking and Vaping Survey.Int J Drug Policy. 2020 May;79:102754. doi: 10.1016/j.drugpo.2020.102754. Epub 2020 Apr 16. Int J Drug Policy. 2020. PMID: 32305827 Free PMC article.
-
Effect of Cannabis on Memory Consolidation, Learning and Retrieval and Its Current Legal Status in India: A Review.Biomolecules. 2023 Jan 12;13(1):162. doi: 10.3390/biom13010162. Biomolecules. 2023. PMID: 36671547 Free PMC article. Review.
-
Theory-based correlates of cannabis use and intentions among US and Israeli adults: a mixed methods study.Subst Abuse Treat Prev Policy. 2023 Sep 6;18(1):54. doi: 10.1186/s13011-023-00562-x. Subst Abuse Treat Prev Policy. 2023. PMID: 37674246 Free PMC article.
References
-
- United Nations Office for Drugs and Crime. The world drug report 2016. New York: United Nations, 2016.
-
- European Monitoring Center for Drugs and Drug Addiction. Decriminalisation in Europe? Recent developments in legal approaches to drug use. European Legal Database on Drugs (ELDD) comparative study. European Legal Database on Drugs. Lisbon: EMCDDA, 2001.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical